tiprankstipranks
Trending News
More News >
MANAC Chemical Partners Co.,Ltd (JP:4360)
:4360
Japanese Market

MANAC Chemical Partners Co.,Ltd (4360) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4360

MANAC Chemical Partners Co.,Ltd

(4360)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
¥853.00
▲(29.24% Upside)
The score is held back primarily by weakened financial performance, including a return to losses and negative free cash flow over the last two years, despite a low-debt balance sheet. Technical momentum is a meaningful support, but overbought indicators raise near-term risk. Valuation is constrained by loss-making results, with only modest support from the dividend yield.
Positive Factors
Conservative balance sheet
A virtually debt-free capital structure materially reduces refinancing and interest-rate risk, preserving financial optionality. Over the medium term this supports resilience through downturns and gives management room to fund restructuring, M&A or capex without burdening cash flow.
Prior profitability track record
Strong margins and profitability in 2022–2023 indicate the business model can generate healthy returns and that recent losses may be cyclical or remediable. This track record supports potential operational recovery if cost structure, pricing or mix are addressed over the next few quarters.
Industry exposure — Chemicals
Operating in the chemicals sector provides exposure to diversified industrial end-markets and generally stable, structural demand drivers. Over months this supports steady baseline volumes and potential pricing leverage versus more cyclical consumer sectors.
Negative Factors
Return to sizable loss
A material swing to a sizable net loss erodes retained equity and signals persistent margin or cost issues. If losses persist, they impair reinvestment capacity, weaken stakeholder confidence, and raise the probability of capital raises or asset sales over the medium term.
Negative free cash flow
Consecutive years of negative free cash flow indicate the company is burning cash or investing above internally generated funds. This reduces financial flexibility, limits ability to self-fund growth or restructuring, and increases reliance on external financing if the trend continues.
Two years of revenue decline
Sustained top-line contraction suggests weakening demand, pricing pressure, or market share loss. Coupled with margin compression, ongoing revenue decline undermines scale economics and makes durable profitability recovery more difficult without structural changes.

MANAC Chemical Partners Co.,Ltd (4360) vs. iShares MSCI Japan ETF (EWJ)

MANAC Chemical Partners Co.,Ltd Business Overview & Revenue Model

Company DescriptionMANAC Chemical Partners Co.,Ltd, together with its subsidiaries, engages in the development, manufacture, sale, import, and export of industrial chemicals and pharmaceuticals in Japan. It is also involved in the supply of raw materials, including flame retardants, antibacterial agents, veterinary drugs, food additives, photosensitive materials, and other materials to technological industries of various fields. In addition, the company provides warehouse leasing services. MANAC Chemical Partners Co.,Ltd was founded in 1948 and is based in Tokyo, Japan.
How the Company Makes MoneyMANAC Chemical Partners Co., Ltd generates revenue through the production and sale of specialty chemicals used in various industrial applications. The company's primary revenue streams include the sale of chemical products to industries like pharmaceuticals, agriculture, and electronics, among others. Additionally, the company may engage in strategic partnerships and collaborations with other firms to enhance its product offerings and expand its market reach. Factors contributing to its earnings include its focus on innovation, efficient production processes, and maintaining strong relationships with its clients.

MANAC Chemical Partners Co.,Ltd Financial Statement Overview

Summary
Financial performance is pressured: profitability deteriorated to a sizable loss in 2025 with margin compression and two years of revenue decline. Cash generation is a key weakness with negative free cash flow in 2024–2025. The main offset is a conservative balance sheet with essentially no debt, though equity declined into 2025.
Income Statement
34
Negative
Profitability weakened materially: the company moved from healthy profits in 2022–2023 (net margin ~6.7%–6.9%) to near-breakeven in 2024 and a sizable loss in 2025 (net margin about -9.6%), with EBIT also turning meaningfully negative. Revenue has also declined for two consecutive years (down ~0.2% in 2024 and ~5.2% in 2025), and gross margin compressed from ~23.7% (2023) to ~15.8% (2025). The main positive is the history of solid profitability in 2022–2023, but the recent margin and earnings deterioration drives the below-average score.
Balance Sheet
72
Positive
The balance sheet looks conservative with essentially no debt in 2024–2025 (debt-to-equity at 0.0), reducing refinancing and interest-rate risk. However, equity fell from 2024 to 2025, and returns declined sharply with negative return on equity in 2025, reflecting the latest-year loss. Overall, the capital structure is a clear strength, but profitability pressure is starting to erode the equity base.
Cash Flow
29
Negative
Cash flow quality has deteriorated versus the strong 2023 profile: operating cash flow swung from solidly positive in 2023 to negative in 2024, then only modestly positive in 2025. Free cash flow was negative in both 2024 and 2025, indicating cash burn and/or elevated investment needs. While 2023 showed the business can generate strong cash, the last two years’ negative free cash flow meaningfully weakens financial flexibility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.60B9.30B9.69B11.85B10.70B
Gross Profit1.66B1.47B1.82B2.81B2.43B
EBITDA-182.25M-312.00M545.00M1.62B1.19B
Net Income-767.00M-895.00M82.00M821.00M712.00M
Balance Sheet
Total Assets13.05B12.65B14.10B15.01B13.59B
Cash, Cash Equivalents and Short-Term Investments3.09B2.77B3.29B3.72B2.04B
Total Debt0.000.000.00290.00M291.00M
Total Liabilities2.72B2.34B2.85B3.97B3.29B
Stockholders Equity10.33B10.30B11.25B11.04B10.29B
Cash Flow
Free Cash Flow0.00-411.00M-593.00M1.40B30.00M
Operating Cash Flow0.00108.00M-118.00M1.65B714.00M
Investing Cash Flow0.00-489.00M-231.00M199.00M-422.00M
Financing Cash Flow0.00-126.00M-75.00M-125.00M-200.00M

MANAC Chemical Partners Co.,Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price660.00
Price Trends
50DMA
690.40
Positive
100DMA
635.03
Positive
200DMA
577.14
Positive
Market Momentum
MACD
43.64
Negative
RSI
68.90
Neutral
STOCH
45.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4360, the sentiment is Positive. The current price of 660 is below the 20-day moving average (MA) of 772.40, below the 50-day MA of 690.40, and above the 200-day MA of 577.14, indicating a bullish trend. The MACD of 43.64 indicates Negative momentum. The RSI at 68.90 is Neutral, neither overbought nor oversold. The STOCH value of 45.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4360.

MANAC Chemical Partners Co.,Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥7.32B6.311.96%8.43%2.99%
72
Outperform
¥8.49B12.652.97%9.92%-27.64%
71
Outperform
¥12.29B14.221.81%9.07%
71
Outperform
¥12.82B134.391.06%-9.63%-1.71%
69
Neutral
¥3.54B10.564.25%7.90%-39.51%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
53
Neutral
¥7.25B-23.171.93%13.64%-151.98%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4360
MANAC Chemical Partners Co.,Ltd
840.00
219.72
35.42%
JP:4040
NANKAI CHEMICAL COMPANY LIMITED
3,140.00
958.29
43.92%
JP:4366
Daito Chemix Corporation
371.00
159.68
75.56%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
389.00
135.51
53.46%
JP:4885
MUROMACHI CHEMICALS INC.
961.00
28.50
3.06%
JP:4960
Chemipro Kasei Kaisya,Ltd.
780.00
464.26
147.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 06, 2026